APLT
Closed
Applied Therapeutics Inc
0.32
+0.01 (+3.21%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 0.3111
Day's Range: 0.303 - 0.329
Send
sign up or login to leave a comment!
When Written:
0.8111
Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops novel drugs for the treatment of various diseases. The company's focus is on developing drugs that target diseases caused by dysfunctions in the body's metabolic pathways. Applied Therapeutics is headquartered in New York City and was founded in 2016. The company's lead drug candidate is AT-007, which is being developed for the treatment of Galactosemia, a rare genetic disorder that affects the body's ability to process galactose. Applied Therapeutics is also developing drugs for the treatment of Diabetic Cardiomyopathy, Diabetic Peripheral Neuropathy, and Cerebral Adrenoleukodystrophy. The company's mission is to improve the lives of patients with unmet medical needs through the development of innovative therapies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








